AAAAAA
Results:
1-23
|
Results: 23
Authors:
Gregory, CW
He, B
Wilson, EM
Citation: Cw. Gregory et al., The putative androgen receptor-A form results from in vitro proteolysis, J MOL ENDOC, 27(3), 2001, pp. 309-319
Authors:
Curtin, D
Jenkins, S
Farmer, N
Anderson, AC
Haisenleder, DJ
Rissman, E
Wilson, EM
Shupnik, MA
Citation: D. Curtin et al., Androgen suppression of GnRH-stimulated rat LH beta gene transcription occurs through Sp1 sites in the distal GnRH-responsive promoter region, MOL ENDOCR, 15(11), 2001, pp. 1906-1917
Authors:
Jenkins, R
Angus, RA
McNatt, H
Howell, WM
Kemppainen, JA
Kirk, M
Wilson, EM
Citation: R. Jenkins et al., Identification of androstenedione in a river containing paper mill effluent, ENV TOX CH, 20(6), 2001, pp. 1325-1331
Authors:
Wilson, EM
Oh, Y
Hwa, V
Rosenfeld, RG
Citation: Em. Wilson et al., Interaction of IGF-binding protein-related protein 1 with a novel protein,neuroendocrine differentiation factor, results in neuroendocrine differentiation of prostate cancer cells, J CLIN END, 86(9), 2001, pp. 4504-4511
Authors:
Buckway, CK
Wilson, EM
Ahlsen, M
Bang, P
Oh, Y
Rosenfeld, RG
Citation: Ck. Buckway et al., Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding, J CLIN END, 86(10), 2001, pp. 4943-4950
Authors:
He, B
Bowen, NT
Minges, JT
Wilson, EM
Citation: B. He et al., Androgen-induced NH2- and COOH-terminal interaction inhibits p160 coactivator recruitment by activation function 2, J BIOL CHEM, 276(45), 2001, pp. 42293-42301
Authors:
Tureckova, J
Wilson, EM
Cappalonga, JL
Rotwein, P
Citation: J. Tureckova et al., Insulin-like growth factor-mediated muscle differentiation - Collaborationbetween phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin, J BIOL CHEM, 276(42), 2001, pp. 39264-39270
Authors:
Walker, GE
Wilson, EM
Powell, D
Oh, Y
Citation: Ge. Walker et al., Butyrate, a histone deacetylase inhibitor, activates the human IGF bindingprotein-3 promoter in breast cancer cells: Molecular mechanism involves anSp1/Sp3 multiprotein complex, ENDOCRINOL, 142(9), 2001, pp. 3817-3827
Authors:
Gregory, CW
Johnson, RT
Mohler, JL
French, FS
Wilson, EM
Citation: Cw. Gregory et al., Androgen receptor stabilization in recurrent prostate cancer is associatedwith hypersensitivity to low androgen, CANCER RES, 61(7), 2001, pp. 2892-2898
Authors:
Gregory, CW
He, B
Johnson, RT
Ford, OH
Mohler, JL
French, FS
Wilson, EM
Citation: Cw. Gregory et al., A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy, CANCER RES, 61(11), 2001, pp. 4315-4319
Authors:
Liao, MM
Wilson, EM
Citation: Mm. Liao et Em. Wilson, Production and purification of histidine-tagged dihydrotestosterone-bound full-length human androgen receptor, METH MOL B, 176, 2001, pp. 67-79
Authors:
Massaad, C
Garlatti, M
Wilson, EM
Cadepond, F
Barouki, R
Citation: C. Massaad et al., A natural sequence consisting of overlapping glucocorticoid-responsive elements mediates glucocorticoid, but not androgen, regulation of gene expression, BIOCHEM J, 350, 2000, pp. 123-129
Authors:
Johnson, BA
Wilson, EM
Li, Y
Moller, DE
Smith, RG
Zhou, GC
Citation: Ba. Johnson et al., Ligand-induced stabilization of PPAR gamma monitored by NMR spectroscopy: Implications for nuclear receptor activation, J MOL BIOL, 298(2), 2000, pp. 187-194
Authors:
He, B
Kemppainen, JA
Wilson, EM
Citation: B. He et al., FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor, J BIOL CHEM, 275(30), 2000, pp. 22986-22994
Authors:
Kemppainen, JA
Langley, E
Wong, CI
Bobseine, K
Kelce, WR
Wilson, EM
Citation: Ja. Kemppainen et al., Distinguishing androgen receptor agonists and antagonists: Distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone, MOL ENDOCR, 13(3), 1999, pp. 440-454
Authors:
Leon, MD
Wilson, EM
Citation: Md. Leon et Em. Wilson, Development of a statewide protocol for the prehospital identification of DNR patients in Connecticut including new DNR regulations, ANN EMERG M, 34(2), 1999, pp. 263-274
Authors:
Wilson, EM
Citation: Em. Wilson, Certification for the professional traffic operations engineer: Status andfuture plans, ITE J, 69(2), 1999, pp. 22-23
Authors:
Burren, CP
Wilson, EM
Hwa, V
Oh, Y
Rosenfeld, RG
Citation: Cp. Burren et al., Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP superfamily, J CLIN END, 84(3), 1999, pp. 1096-1103
Authors:
He, B
Kemppainen, JA
Voegel, JJ
Gronemeyer, H
Wilson, EM
Citation: B. He et al., Activation function 2 in the human androgen receptor ligand binding domainmediates interdomain communication with the NH2-terminal domain, J BIOL CHEM, 274(52), 1999, pp. 37219-37225
Authors:
Yamanaka, Y
Fowlkes, JL
Wilson, EM
Rosenfeld, RG
Oh, Y
Citation: Y. Yamanaka et al., Characterization of insulin-like growth factor binding protein-3 (IGFBP-3)binding to human breast cancer cells: Kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule, ENDOCRINOL, 140(3), 1999, pp. 1319-1328
Authors:
Liao, MM
Zhou, ZX
Wilson, EM
Citation: Mm. Liao et al., Redox-dependent DNA binding of the purified androgen receptor: Evidence for disulfide-linked androgen receptor dimers, BIOCHEM, 38(30), 1999, pp. 9718-9727
Authors:
Hwa, V
Oh, Y
Burren, CP
Choi, WK
Graham, DL
Ingermann, A
Kim, HS
Lopez-Bermejo, A
Minniti, G
Nagalla, SR
Pai, K
Spagnoli, A
Vorwerk, P
Wanek, DLV
Wilson, EM
Yamanaka, Y
Yang, DH
Rosenfeld, RG
Citation: V. Hwa et al., The IGF binding protein superfamily, CONT ENDOC, 17, 1999, pp. 315-327
Authors:
Choong, CS
Wilson, EM
Citation: Cs. Choong et Em. Wilson, Trinucleotide repeats in the human androgen receptor: a molecular basis for disease, J MOL ENDOC, 21(3), 1998, pp. 235-257
Risultati:
1-23
|